Skip to main content

Table 3 Number of studies included in this systematic review reporting on individual GLASS pathogens in fragile and conflict affected Countries

From: Antimicrobial resistance among GLASS pathogens in conflict and non-conflict affected settings in the Middle East: a systematic review

GLASS pathogen

Country N* (References)

References

Djibouti (Tot N = 0)

Iraq (Tot N = 24)

Israel/OPT (Tot N = 7)

Lebanon (Tot N = 9)

Libya (Tot N = 6)

Syria (Tot N = 4)

Yemen (Tot N = 1)

Total (%) (N = 51)

Acinetobacter spp.

–

4/24

–

6/9

2/6

–

–

12/51 (23.5%)

[44, 50, 106, 109, 111, 115, 127, 129, 143, 160, 170, 174]

E. coli

–

5/24

2/7

1/9

5/6

3/4

–

16/51 (31.4%)

[44, 45, 50, 55, 62, 74, 82, 86, 114, 119, 131, 144, 150, 154, 162, 163]

K. pneumoniae

–

6/24

–

–

2/6

–

–

8/51 (15.7%)

[89, 91, 109, 117, 122, 161, 163, 165]

N. gonorrhoeae

–

–

–

–

–

–

–

0/51 (0%)

NA

Salmonella spp.

–

1/24

–

2/9

–

–

–

3/51 (5.9%)

[50, 140, 152]

Shigella spp.

–

1/24

–

1/9

–

–

–

2/51 (3.9%)

[50, 66]

S. aureus

–

6/24

4/7

2/9

–

2/4

1/1

15/51 (29.4%)

[50, 53, 54, 61, 63, 64, 73, 85, 101, 102, 118, 126, 131, 132, 147]

S. pneumoniae

–

1/24

1/7

2/9

–

–

1/1

5/51 (9.8%)

[50, 58, 126, 130, 159]

  1. * Articles can report antibiotic resistance profile on more than one pathogen, and therefore the sum of the articles in this table can differ from the total per Country detailed
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us